CSL425

BIOLOGICAL3 trials

Sponsors

Seqirus

Conditions

InfluenzaInfluenza Caused by the Novel Influenza A (H1N1) Virus

Phase 2

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

CompletedNCT00938639

SeqirusInfluenza Caused by the Novel Influenza A (H1N1) Virus

Start: 2009-07-31End: 2010-03-31Updated: 2018-06-28

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children

CompletedNCT00940108

SeqirusInfluenza Caused by the Novel Influenza A (H1N1) Virus

Start: 2009-08-31End: 2010-04-30Updated: 2018-06-28

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA

CompletedNCT00958126

SeqirusInfluenza

Start: 2009-08-31End: 2010-04-30Updated: 2017-11-21

Related Papers

A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

2010-11-0135 citations

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

2009-12-21138 citations

Response to a monovalent 2009 influenza A (H1N1) vaccine.

2009-09-10350 citations